Physician profile
Aravdeep Jhand
NPI 1487100731
$7,279.07
in general payments reported to CMS, 2019-2025
14 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $301 · 2021: $432 · 2022: $3,182 · 2023: $989 · 2024: $1,778 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,614 · Food and Beverage: $1,398 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,613.74 |
| Food and Beverage | $1,397.66 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,164.88 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $1,730.79 | 2022-2023 | Corevalve Evolut R |
| Abbott Laboratories | $1,140.56 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $988.71 | 2022-2024 | Gore Cardioform Septal Occluder |
| Boston Scientific Corporation | $251.91 | 2021-2023 | Opticross, Rotablator Rotational Atherectomy System Console Kit |
| Philips North America LLC | $170.05 | 2024 | (Bh4) Igt Devices Undivided, (9520) Igt Devices Undivided |
| Astellas Pharma US INC | $169.98 | 2021 | |
| Abiomed | $156.72 | 2023-2024 | Impella |
| Cardiovascular Systems INC. | $148.00 | 2022 | |
| Heartflow, INC. | $123.80 | 2025 | |
| Ge Healthcare | $100.21 | 2022 | |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Asahi Intecc USA, INC. | $37.24 | 2022-2023 | Asahi Ptca Guide Wire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aravdeep Jhand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.